Employers could face new federal rules for how their health plans cover insulin for children with diabetes. The new Making Insulin Affordable for All Children Act bill would require any group ...

The out-of-pocket cost cap of $£35 at participating retail ... As the BBC reported, a 2020 Rand study found that the average price per vial of insulin in the US was more than $98 in 2018 ...

If passed, the Affordable Insulin Now Act would apply the cap across both private health ... The company said its products will cost no more than $30 per vial or $55 for five pen cartridges ...

The action is intended to build upon the existing program for Medicare drug price negotiations, which was created by the Inflation Reduction Act that passed during the Biden administration.

Throw open the door to your book cage! Joe Goldberg returns to where it all began in the final season of Netflix's killer hit ...

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation ...

Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part ...

This week, federal health officials finalized a set of rules tied to the last leg of the 2022 Inflation Reduction Act. The list includes a cap on insulin cost at $35 a month.